The Roopa Screen IPO is a closed SME Bookbuilding offer (Fresh capital only) that opened on 24 September 2026. The Roopa Screen IPO closed on 28 September 2026, with an issue price of ₹64 per share. The Roopa Screen IPO has a face value of ₹10 and a lot size of 2,000 shares. The Roopa Screen IPO size aggregates up to ₹19 crore, listing on BSE SME on 1 October 2026. The Roopa Screen IPO allotment was scheduled for 29 September 2026.
On the financial front, the Roopa Screen IPO reported revenue of ₹46 crore for 31 Mar 2025, compared with ₹36 crore for 31 Mar 2024. The Roopa Screen IPO PAT was ₹5 crore against ₹2 crore. The Roopa Screen IPO EBITDA stood at ₹8 crore with a 19.72% margin. The Roopa Screen IPO net worth as of 31 Mar 2025 was ₹10 crore.
Always verify The Roopa Screen IPO details and GMP data with the official offer document before investing in the Roopa Screen IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2025
31 Mar 2024
31 Mar 2023
Total Assets
22
20
23
Revenue
46
36
35
PAT
5
2
1
EBITDA
8
4
2
Net Worth
10
5
4
Reserves
9
4
3
Total Borrowing
7
9
11
Roopa Screen IPO Financials FAQs
Revenue of Roopa Screen (Amount in ₹ Crore) — 31 Mar 2025: 46; 31 Mar 2024: 36; 31 Mar 2023: 35. Profit after tax (PAT) — 31 Mar 2025: 5; 31 Mar 2024: 2; 31 Mar 2023: 1.
EBITDA of Roopa Screen (Amount in ₹ Crore) — 31 Mar 2025: 8; 31 Mar 2024: 4; 31 Mar 2023: 2. The EBITDA margin is 19.72%.
Total assets — 31 Mar 2025: 22; 31 Mar 2024: 20; 31 Mar 2023: 23. Net worth — 31 Mar 2025: 10; 31 Mar 2024: 5; 31 Mar 2023: 4. Reserves & surplus — 31 Mar 2025: 9; 31 Mar 2024: 4; 31 Mar 2023: 3. (Amount in ₹ Crore)
Total borrowing of Roopa Screen (Amount in ₹ Crore) — 31 Mar 2025: 7; 31 Mar 2024: 9; 31 Mar 2023: 11. Debt-to-equity ratio: 0.45.
The financials shown for Roopa Screen IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.